4BMK
Serine Palmitoyltransferase K265A from S. paucimobilis with bound PLP- Myriocin Aldimine
4BMK の概要
| エントリーDOI | 10.2210/pdb4bmk/pdb |
| 分子名称 | SERINE PALMITOYLTRANSFERASE, PYRIDOXAL-5'-PHOSPHATE, Decarboxylated Myriocin, ... (5 entities in total) |
| 機能のキーワード | transferase-antibiotic complex, transferase, external aldimine, inhibitor, sphingolipids, natural product, antibiotic isp-1, transferase/antibiotic |
| 由来する生物種 | SPHINGOMONAS PAUCIMOBILIS |
| タンパク質・核酸の鎖数 | 2 |
| 化学式量合計 | 96081.49 |
| 構造登録者 | Wadsworth, J.M.,Clarke, D.J.,McMahon, S.A.,Beattie, A.E.,Lowther, J.,Dunn, T.M.,Naismith, J.H.,Campopiano, D.J. (登録日: 2013-05-09, 公開日: 2013-09-04, 最終更新日: 2023-12-20) |
| 主引用文献 | Wadsworth, J.M.,Clarke, D.J.,Mcmahon, S.A.,Lowther, J.P.,Beattie, A.E.,Langridge-Smith, P.R.R.,Broughton, H.B.,Dunn, T.M.,Naismith, J.H.,Campopiano, D.J. The Chemical Basis of Serine Palmitoyltransferase Inhibition by Myriocin. J.Am.Chem.Soc., 135:14276-, 2013 Cited by PubMed Abstract: Sphingolipids (SLs) are essential components of cellular membranes formed from the condensation of L-serine and a long-chain acyl thioester. This first step is catalyzed by the pyridoxal-5'-phosphate (PLP)-dependent enzyme serine palmitoyltransferase (SPT) which is a promising therapeutic target. The fungal natural product myriocin is a potent inhibitor of SPT and is widely used to block SL biosynthesis despite a lack of a detailed understanding of its molecular mechanism. By combining spectroscopy, mass spectrometry, X-ray crystallography, and kinetics, we have characterized the molecular details of SPT inhibition by myriocin. Myriocin initially forms an external aldimine with PLP at the active site, and a structure of the resulting co-complex explains its nanomolar affinity for the enzyme. This co-complex then catalytically degrades via an unexpected 'retro-aldol-like' cleavage mechanism to a C18 aldehyde which in turn acts as a suicide inhibitor of SPT by covalent modification of the essential catalytic lysine. This surprising dual mechanism of inhibition rationalizes the extraordinary potency and longevity of myriocin inhibition. PubMed: 23957439DOI: 10.1021/JA4059876 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (1.62 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






